
Myocardial Protecting Role of Glutamine in Patients with Low Ejection Fraction Undergoing Elective On-Pump Coronary Artery Bypass Graft Surgery
Author(s) -
I Made Adi Parmana,
Cindy Elfira Boom,
Lisnawati Rachmadi,
Dudy Arman Hanafy,
Yunita Widyastuti,
Muchtaruddin Mansyur,
Bambang Budi Siswanto
Publication year - 2022
Publication title -
vascular health and risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.892
H-Index - 68
eISSN - 1178-2048
pISSN - 1176-6344
DOI - 10.2147/vhrm.s361298
Subject(s) - medicine , ejection fraction , glutamine , cardiopulmonary bypass , ventricle , troponin t , artery , cardiology , troponin i , troponin , anesthesia , surgery , heart failure , myocardial infarction , biochemistry , chemistry , amino acid
Myocardial injury due to on-pump coronary artery bypass grafting (CABG) in patients with low ejection fraction (EF) is associated with poor outcomes. This study determines whether intravenous glutamine could protect the myocardium during on-pump CABG in patients with low EF.